Sung is a counsel in the Life Sciences Health Industry Group in the Washington D.C. office. Sung provides counsel to companies during both the pre-market and post-market phases of product life cycles. He guides companies in developing, distributing, and marketing FDA-regulated products and, when necessary, in responding to regulatory and administrative enforcement actions by federal and state agencies such as FDA, USDA, and state attorneys general offices. Sung understands the unique business landscape of FDA-regulated products, and provides practical advice that suits the needs of the client’s business.